Anti-tumor
Showing 26 - 50 of >10,000
Hepatocellular Carcinoma Trial (ABSK-011 180 mg QD combined with atilizumab 1200 mg q3w)
Not yet recruiting
- Hepatocellular Carcinoma
- ABSK-011 180 mg QD combined with atilizumab 1200 mg q3w
- (no location specified)
Jun 28, 2022
Peripheral T Cell Lymphoma Trial in Zhengzhou (Golidocitinib, CHOP Regimen)
Not yet recruiting
- Peripheral T Cell Lymphoma
- Golidocitinib
- CHOP Regimen
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
Jul 18, 2023
Metastatic Castration Resistant Prostate Cancer Trial in London (IMU-935)
Recruiting
- Metastatic Castration Resistant Prostate Cancer
-
London, United KingdomInstitute of Cancer Research
Jan 31, 2023
Advanced Malignant Cancer Trial (SHR-2022 Injection)
Not yet recruiting
- Advanced Malignant Cancer
- SHR-2022 Injection
- (no location specified)
Nov 8, 2023
Metastatic Castration-resistant Prostate Cancer Trial (HP518 - Dose Escalation, HP518 -Dose Expansion)
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- HP518 - Dose Escalation
- HP518 -Dose Expansion
- (no location specified)
Dec 1, 2023
Colorectal Adenocarcinoma, Mucinous Adenocarcinoma, Signet Ring Cell Adenocarcinoma Trial in Trondheim, Lørenskog, Oslo
Not yet recruiting
- Colorectal Adenocarcinoma
- +2 more
-
Trondheim, Trondelag, Norway
- +2 more
Aug 15, 2022
Advanced Malignant Tumors Trial (NBL-020 for Injection)
Not yet recruiting
- Advanced Malignant Tumors
- NBL-020 for Injection
- (no location specified)
May 18, 2023
Non-muscle Invasive Bladder Cancer Trial (TARA-002)
Not yet recruiting
- Non-muscle Invasive Bladder Cancer
- TARA-002
- (no location specified)
Jul 14, 2023
Stage IIIA Hepatocellular Carcinoma Trial (Radiotherapy combined with TKI and Anti-PD-1 Antibody)
Not yet recruiting
- Stage IIIA Hepatocellular Carcinoma
- Radiotherapy combined with TKI and Anti-PD-1 Antibody
- (no location specified)
Sep 24, 2023
Hepatocellular Carcinoma, Liver Metastases, Cholangiocarcinoma Trial in United States (STP705)
Active, not recruiting
- Hepatocellular Carcinoma
- +2 more
-
Scottsdale, Arizona
- +4 more
Dec 13, 2022
Advanced Solid Tumor, Refractory Non-Hodgkin Lymphoma Trial (HCB101)
Not yet recruiting
- Advanced Solid Tumor
- Refractory Non-Hodgkin Lymphoma
- (no location specified)
May 28, 2023
HER2-positive Breast Cancer, Operable Breast Cancer Trial in France (Trastuzumab + Paclitaxel, Pegfilgrastim)
Recruiting
- HER2-positive Breast Cancer
- Operable Breast Cancer
- Trastuzumab + Paclitaxel
- Pegfilgrastim
-
Avignon, France
- +8 more
Jan 9, 2023
Renal Cell Carcinoma, NSCLC, Pancreatic Adenocarcinoma, Colorectal Cancer Trial (RO7515629, tocilizumab)
Not yet recruiting
- Renal Cell Carcinoma, Non-small Cell Lung Cancer, Pancreatic Adenocarcinoma, Colorectal Cancer
- (no location specified)
Mar 3, 2023
Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Solid Tumor Trial (TYRA-300)
Not yet recruiting
- Locally Advanced Urothelial Carcinoma
- +3 more
- (no location specified)
Sep 15, 2022
Metastatic Castration Resistant Prostate Cancer Trial in New York, Pittsburgh, Seoul (DZD2269)
Terminated
- Metastatic Castration Resistant Prostate Cancer
-
New York, New York
- +5 more
Jul 6, 2022
HER2-positive Advanced Solid Tumor Trial in Zigong (ZV0203)
Enrolling by invitation
- HER2-positive Advanced Solid Tumor
-
Zigong, Shandong, ChinaPKUCare Luzhong Hospital
Jun 14, 2022
Metastatic Breast Cancer Trial in Worldwide (Ixabepilone Injection)
Recruiting
- Metastatic Breast Cancer
- Ixabepilone Injection
-
Aalst, Belgium
- +11 more
Nov 28, 2022
Oral Squamous Cell Carcinoma Trial (PRV211 (Intraoperative Cisplatin System))
Not yet recruiting
- Oral Squamous Cell Carcinoma
- PRV211 (Intraoperative Cisplatin System)
- (no location specified)
May 30, 2023
Metastatic Castration-resistant Prostate Cancer Trial in Australia (HP518 - Dose Escalation, HP518 - Dose expansion)
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- HP518 - Dose Escalation
- HP518 - Dose expansion
-
Albury, New South Wales, Australia
- +4 more
May 5, 2022
Lymphoma, Non-Hodgkin Trial in Perth (DZD8586)
Not yet recruiting
- Lymphoma, Non-Hodgkin
-
Perth, Western Australia, AustraliaLinear Clinical Research Ltd
Apr 20, 2023